ArticleBiomedicines2022

Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer's Disease.

David Vicente-Zurdo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.